<!doctype html><!-- This site was created with Wowchemy. https://www.wowchemy.com --><!-- Last Published: 2023. május 31. --><html lang=hu><head><meta charset=utf-8><meta name=viewport content="width=device-width,initial-scale=1"><meta http-equiv=x-ua-compatible content="IE=edge"><meta name=generator content="Wowchemy 5.7.0 for Hugo"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=preload as=style href="https://fonts.googleapis.com/css2?family=Montserrat:wght@400;700&family=Roboto+Mono&family=Roboto:wght@400;700&display=swap"><link rel=stylesheet href="https://fonts.googleapis.com/css2?family=Montserrat:wght@400;700&family=Roboto+Mono&family=Roboto:wght@400;700&display=swap" media=print onload='this.media="all"'><link rel=stylesheet href=/css/vendor-bundle.min.16f785cdb553c8c4431db6775122af35.css media=print onload='this.media="all"'><link rel=stylesheet href=https://cdn.jsdelivr.net/npm/academicons@1.9.2/css/academicons.min.css integrity="sha512-KlJCpRsLf+KKu2VQa5vmRuClRFjxc5lXO03ixZt82HZUk41+1I0bD8KBSA0fY290ayMfWYI9udIqeOWSu1/uZg==" crossorigin=anonymous media=print onload='this.media="all"'><link rel=stylesheet href=/css/wowchemy.0f229d4b7ebad1917a9a357cba2effab.css><link rel=stylesheet href=/css/libs/chroma/github-light.min.css title=hl-light media=print onload='this.media="all"'><link rel=stylesheet href=/css/libs/chroma/dracula.min.css title=hl-dark media=print onload='this.media="all"' disabled><script async src="https://www.googletagmanager.com/gtag/js?id=G-YGBRWXZLM1"></script>
<script>window.dataLayer=window.dataLayer||[];function gtag(){dataLayer.push(arguments)}function trackOutboundLink(e,t){gtag("event","click",{event_category:"outbound",event_label:e,transport_type:"beacon",event_callback:function(){t!=="_blank"&&(document.location=e)}}),console.debug("Outbound link clicked: "+e)}function onClickCallback(e){if(e.target.tagName!=="A"||e.target.host===window.location.host)return;trackOutboundLink(e.target,e.target.getAttribute("target"))}gtag("js",new Date),gtag("config","G-YGBRWXZLM1",{}),gtag("set",{cookie_flags:"SameSite=None;Secure"}),document.addEventListener("click",onClickCallback,!1)</script><script>(function(e,t,n,s,o,i,a){e[n]=e[n]||function(){(e[n].q=e[n].q||[]).push(arguments)},i=t.createElement(s),i.async=1,i.src="https://www.clarity.ms/tag/"+o,a=t.getElementsByTagName(s)[0],a.parentNode.insertBefore(i,a)})(window,document,"clarity","script","h7uhlm8mdb")</script><meta name=author content="Ferenci Tamás"><meta name=description content="Objective:Characterizing blood glucose curves and providing precise patient level risk assessment of hyperglycemia using extreme value statistics and comparing these assessments with traditional indicators of glycemic variability which are not designed to specifically capture the risk of hyperglycemia.Research Design and Methods:One year return level (blood glucose level exceeded exactly once every year on average) and probability of exceeding and expected time spent above certain thresholds (600 and 400 mg/dL) per year were calculated. As a comparison, traditional metrics for glycemic variability were determined too. The effect of body mass index on extremes was also investigated using non-stationary models. Metrics were calculated on a dataset containing 170.8 patient-years of measurements of 226 patients.Results:Nine high-risk patients were identified with the novel metrics: their estimated time spent above 600 mg/dL per year were above 2 hours. These patients were at moderate risk according to the traditional metrics. Higher body mass index was associated with more extreme glucose levels.Conclusions:Through these estimates it is possible to assess each patient?s individual clinical risk of hyperglycemia even beyond the observed blood glucose levels and detection limits. Additionally, it allows the assessment of the impact of clinical characteristics and treatments on blood glucose control in a novel, mathematically well-founded and potentially clinically more useful way than the already existing indicators."><link rel=alternate hreflang=hu href=https://www.medstat.hu/publication/mtmt-32555954/><link rel=canonical href=https://www.medstat.hu/publication/mtmt-32555954/><link rel=manifest href=/manifest.webmanifest><link rel=icon type=image/png href=/media/icon_hu577da21a7a63fbc8612c74418210a2c7_11440_32x32_fill_lanczos_center_3.png><link rel=apple-touch-icon type=image/png href=/media/icon_hu577da21a7a63fbc8612c74418210a2c7_11440_180x180_fill_lanczos_center_3.png><meta name=theme-color content="#1565c0"><meta property="twitter:card" content="summary_large_image"><meta property="twitter:image" content="https://www.medstat.hu/media/sharing.png"><meta property="og:site_name" content="Ferenci Tamás honlapja"><meta property="og:url" content="https://www.medstat.hu/publication/mtmt-32555954/"><meta property="og:title" content="The Use of Extreme Value Statistics to Characterize Blood Glucose Curves and Patient Level Risk Assessment of Patients With Type I Diabetes | Ferenci Tamás honlapja"><meta property="og:description" content="Objective:Characterizing blood glucose curves and providing precise patient level risk assessment of hyperglycemia using extreme value statistics and comparing these assessments with traditional indicators of glycemic variability which are not designed to specifically capture the risk of hyperglycemia.Research Design and Methods:One year return level (blood glucose level exceeded exactly once every year on average) and probability of exceeding and expected time spent above certain thresholds (600 and 400 mg/dL) per year were calculated. As a comparison, traditional metrics for glycemic variability were determined too. The effect of body mass index on extremes was also investigated using non-stationary models. Metrics were calculated on a dataset containing 170.8 patient-years of measurements of 226 patients.Results:Nine high-risk patients were identified with the novel metrics: their estimated time spent above 600 mg/dL per year were above 2 hours. These patients were at moderate risk according to the traditional metrics. Higher body mass index was associated with more extreme glucose levels.Conclusions:Through these estimates it is possible to assess each patient?s individual clinical risk of hyperglycemia even beyond the observed blood glucose levels and detection limits. Additionally, it allows the assessment of the impact of clinical characteristics and treatments on blood glucose control in a novel, mathematically well-founded and potentially clinically more useful way than the already existing indicators."><meta property="og:image" content="https://www.medstat.hu/media/sharing.png"><meta property="og:locale" content="hu"><meta property="article:published_time" content="2023-04-10T18:20:28+00:00"><meta property="article:modified_time" content="2023-04-10T20:20:29+02:00"><script type=application/ld+json>{"@context":"https://schema.org","@type":"Article","mainEntityOfPage":{"@type":"WebPage","@id":"https://www.medstat.hu/publication/mtmt-32555954/"},"headline":"The Use of Extreme Value Statistics to Characterize Blood Glucose Curves and Patient Level Risk Assessment of Patients With Type I Diabetes","datePublished":"2023-04-10T18:20:28Z","dateModified":"2023-04-10T20:20:29+02:00","author":{"@type":"Person","name":"Mátyás Szigeti"},"publisher":{"@type":"Organization","name":"Ferenci Tamás honlapja","logo":{"@type":"ImageObject","url":"https://www.medstat.hu/media/icon_hu577da21a7a63fbc8612c74418210a2c7_11440_192x192_fill_lanczos_center_3.png"}},"description":"Objective:Characterizing blood glucose curves and providing precise patient level risk assessment of hyperglycemia using extreme value statistics and comparing these assessments with traditional indicators of glycemic variability which are not designed to specifically capture the risk of hyperglycemia.Research Design and Methods:One year return level (blood glucose level exceeded exactly once every year on average) and probability of exceeding and expected time spent above certain thresholds (600 and 400 mg/dL) per year were calculated. As a comparison, traditional metrics for glycemic variability were determined too. The effect of body mass index on extremes was also investigated using non-stationary models. Metrics were calculated on a dataset containing 170.8 patient-years of measurements of 226 patients.Results:Nine high-risk patients were identified with the novel metrics: their estimated time spent above 600 mg/dL per year were above 2 hours. These patients were at moderate risk according to the traditional metrics. Higher body mass index was associated with more extreme glucose levels.Conclusions:Through these estimates it is possible to assess each patient?s individual clinical risk of hyperglycemia even beyond the observed blood glucose levels and detection limits. Additionally, it allows the assessment of the impact of clinical characteristics and treatments on blood glucose control in a novel, mathematically well-founded and potentially clinically more useful way than the already existing indicators."}</script><title>The Use of Extreme Value Statistics to Characterize Blood Glucose Curves and Patient Level Risk Assessment of Patients With Type I Diabetes | Ferenci Tamás honlapja</title></head><body id=top data-spy=scroll data-offset=70 data-target=#TableOfContents class=page-wrapper data-wc-page-id=f700fc7c9359942fcb01fe795789a112><script src=/js/wowchemy-init.min.ec9d49ca50e4b80bdb08f0417a28ed84.js></script><aside class=search-modal id=search><div class=container><section class=search-header><div class="row no-gutters justify-content-between mb-3"><div class=col-6><h1>Keresés</h1></div><div class="col-6 col-search-close"><a class=js-search href=# aria-label=Close><i class="fas fa-times-circle text-muted" aria-hidden=true></i></a></div></div><div id=search-box><input name=q id=search-query placeholder=Keresés... autocapitalize=off autocomplete=off autocorrect=off spellcheck=false type=search class=form-control aria-label=Keresés...></div></section><section class=section-search-results><div id=search-hits></div></section></div></aside><div class="page-header header--fixed"><header><nav class="navbar navbar-expand-lg navbar-light compensate-for-scrollbar" id=navbar-main><div class=container-xl><div class="d-none d-lg-inline-flex"><a class=navbar-brand href=/>Ferenci Tamás honlapja</a></div><button type=button class=navbar-toggler data-toggle=collapse data-target=#navbar-content aria-controls=navbar-content aria-expanded=false aria-label=Navigáció>
<span><i class="fas fa-bars"></i></span></button><div class="navbar-brand-mobile-wrapper d-inline-flex d-lg-none"><a class=navbar-brand href=/>Ferenci Tamás honlapja</a></div><div class="navbar-collapse main-menu-item collapse justify-content-start" id=navbar-content><ul class="navbar-nav d-md-inline-flex"><li class=nav-item><a class=nav-link href=/#about><span>Rólam</span></a></li><li class=nav-item><a class=nav-link href=/#oktatas><span>Oktatás</span></a></li><li class=nav-item><a class=nav-link href=/#projektek><span>Projektjeim</span></a></li><li class=nav-item><a class=nav-link href=/#esszek><span>Esszéim</span></a></li><li class=nav-item><a class=nav-link href=/#publications><span>Cikkek</span></a></li><li class=nav-item><a class=nav-link href=/#contact><span>Kapcsolat</span></a></li></ul></div><ul class="nav-icons navbar-nav flex-row ml-auto d-flex pl-md-2"><li class=nav-item><a class="nav-link js-search" href=# aria-label=Keresés><i class="fas fa-search" aria-hidden=true></i></a></li><li class="nav-item dropdown theme-dropdown"><a href=# class=nav-link data-toggle=dropdown aria-haspopup=true aria-label="Display preferences"><i class="fas fa-moon" aria-hidden=true></i></a><div class=dropdown-menu><a href=# class="dropdown-item js-set-theme-light"><span>Light</span></a>
<a href=# class="dropdown-item js-set-theme-dark"><span>Dark</span></a>
<a href=# class="dropdown-item js-set-theme-auto"><span>Automatic</span></a></div></li></ul></div></nav></header></div><div class=page-body><div class=pub><div class="article-container pt-3"><h1>The Use of Extreme Value Statistics to Characterize Blood Glucose Curves and Patient Level Risk Assessment of Patients With Type I Diabetes</h1><div class=article-metadata><div><span>Mátyás Szigeti</span>, <span>Tamás Ferenci</span>, <span>Levente Kovács</span></div><span class=article-date>január, 2021</span></div><div class="btn-links mb-3"><a href=# class="btn btn-outline-primary btn-page-header js-cite-modal" data-filename=/publication/mtmt-32555954/cite.bib>Idézet</a>
<a class="btn btn-outline-primary btn-page-header" href=https://doi.org/10.1177/19322968211059547 target=_blank rel=noopener>DOI</a>
<a class="btn btn-outline-primary btn-page-header" href=https://m2.mtmt.hu/api/publication/32555954 target=_blank rel=noopener>URL</a></div></div><div class=article-container><h3>Kivonat</h3><p class=pub-abstract>Objective:Characterizing blood glucose curves and providing precise patient level risk assessment of hyperglycemia using extreme value statistics and comparing these assessments with traditional indicators of glycemic variability which are not designed to specifically capture the risk of hyperglycemia.Research Design and Methods:One year return level (blood glucose level exceeded exactly once every year on average) and probability of exceeding and expected time spent above certain thresholds (600 and 400 mg/dL) per year were calculated. As a comparison, traditional metrics for glycemic variability were determined too. The effect of body mass index on extremes was also investigated using non-stationary models. Metrics were calculated on a dataset containing 170.8 patient-years of measurements of 226 patients.Results:Nine high-risk patients were identified with the novel metrics: their estimated time spent above 600 mg/dL per year were above 2 hours. These patients were at moderate risk according to the traditional metrics. Higher body mass index was associated with more extreme glucose levels.Conclusions:Through these estimates it is possible to assess each patient?s individual clinical risk of hyperglycemia even beyond the observed blood glucose levels and detection limits. Additionally, it allows the assessment of the impact of clinical characteristics and treatments on blood glucose control in a novel, mathematically well-founded and potentially clinically more useful way than the already existing indicators.</p><div class=row><div class=col-md-1></div><div class=col-md-10><div class=row><div class="col-12 col-md-3 pub-row-heading">Típus</div><div class="col-12 col-md-9"><a href=/publication/#2>Journal article</a></div></div></div><div class=col-md-1></div></div><div class="d-md-none space-below"></div><div class=row><div class=col-md-1></div><div class=col-md-10><div class=row><div class="col-12 col-md-3 pub-row-heading">Publikáció</div><div class="col-12 col-md-9"><em>JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY</em></div></div></div><div class=col-md-1></div></div><div class="d-md-none space-below"></div><div class=space-below></div><div class=article-style></div><div class=share-box><ul class=share><li><a href="mailto:?subject=The%20Use%20of%20Extreme%20Value%20Statistics%20to%20Characterize%20Blood%20Glucose%20Curves%20and%20Patient%20Level%20Risk%20Assessment%20of%20Patients%20With%20Type%20I%20Diabetes&amp;body=https%3A%2F%2Fwww.medstat.hu%2Fpublication%2Fmtmt-32555954%2F" target=_blank rel=noopener class=share-btn-email aria-label=envelope><i class="fas fa-envelope"></i></a></li><li><a href="https://www.facebook.com/sharer.php?u=https%3A%2F%2Fwww.medstat.hu%2Fpublication%2Fmtmt-32555954%2F&amp;t=The+Use+of+Extreme+Value+Statistics+to+Characterize+Blood+Glucose+Curves+and+Patient+Level+Risk+Assessment+of+Patients+With+Type+I+Diabetes" target=_blank rel=noopener class=share-btn-facebook aria-label=facebook><i class="fab fa-facebook"></i></a></li><li><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.medstat.hu%2Fpublication%2Fmtmt-32555954%2F&amp;text=The+Use+of+Extreme+Value+Statistics+to+Characterize+Blood+Glucose+Curves+and+Patient+Level+Risk+Assessment+of+Patients+With+Type+I+Diabetes" target=_blank rel=noopener class=share-btn-twitter aria-label=twitter><i class="fab fa-twitter"></i></a></li><li><a href="https://www.linkedin.com/shareArticle?url=https%3A%2F%2Fwww.medstat.hu%2Fpublication%2Fmtmt-32555954%2F&amp;title=The+Use+of+Extreme+Value+Statistics+to+Characterize+Blood+Glucose+Curves+and+Patient+Level+Risk+Assessment+of+Patients+With+Type+I+Diabetes" target=_blank rel=noopener class=share-btn-linkedin aria-label=linkedin-in><i class="fab fa-linkedin-in"></i></a></li><li><a href="https://reddit.com/submit?url=https%3A%2F%2Fwww.medstat.hu%2Fpublication%2Fmtmt-32555954%2F&amp;title=The+Use+of+Extreme+Value+Statistics+to+Characterize+Blood+Glucose+Curves+and+Patient+Level+Risk+Assessment+of+Patients+With+Type+I+Diabetes" target=_blank rel=noopener class=share-btn-reddit aria-label=reddit-alien><i class="fab fa-reddit-alien"></i></a></li></ul></div></div></div></div><div class=page-footer><div class=container><footer class=site-footer><p class="powered-by copyright-license-text">© 2023 Ferenci Tamás. This work is licensed under <a href=https://creativecommons.org/licenses/by-nc-nd/4.0 rel="noopener noreferrer" target=_blank>CC BY NC ND 4.0</a></p><p class="powered-by footer-license-icons"><a href=https://creativecommons.org/licenses/by-nc-nd/4.0 rel="noopener noreferrer" target=_blank aria-label="Creative Commons"><i class="fab fa-creative-commons fa-2x" aria-hidden=true></i>
<i class="fab fa-creative-commons-by fa-2x" aria-hidden=true></i>
<i class="fab fa-creative-commons-nc fa-2x" aria-hidden=true></i>
<i class="fab fa-creative-commons-nd fa-2x" aria-hidden=true></i></a></p><p class=powered-by>Published with <a href="https://wowchemy.com/?utm_campaign=poweredby" target=_blank rel=noopener>Wowchemy</a> — the free, <a href=https://github.com/wowchemy/wowchemy-hugo-themes target=_blank rel=noopener>open source</a> website builder that empowers creators.</p></footer></div></div><script src=/js/vendor-bundle.min.d26509351aa0ff874abbee824e982e9b.js></script>
<script id=search-hit-fuse-template type=text/x-template>
    <div class="search-hit" id="summary-{{key}}">
      <div class="search-hit-content">
        <div class="search-hit-name">
          <a href="{{relpermalink}}">{{title}}</a>
          <div class="article-metadata search-hit-type">{{type}}</div>
          <p class="search-hit-description">{{snippet}}</p>
        </div>
      </div>
    </div>
  </script><script src=https://cdn.jsdelivr.net/gh/krisk/Fuse@v3.2.1/dist/fuse.min.js integrity="sha512-o38bmzBGX+hD3JHWUFCDA09btWaqrNmoJ3RXLlrysA7PP01Kgs4UlE4MhelE1v5dJR3+cxlR4qQlotsW7jKsnw==" crossorigin=anonymous></script>
<script src=https://cdn.jsdelivr.net/gh/julmot/mark.js@8.11.1/dist/jquery.mark.min.js integrity="sha512-mhbv5DqBMgrWL+32MmsDOt/OAvqr/cHimk6B8y/bx/xS88MVkYGPiVv2ixKVrkywF2qHplNRUvFsAHUdxZ3Krg==" crossorigin=anonymous></script>
<script id=page-data type=application/json>{"use_headroom":true}</script><script src=/js/wowchemy-headroom.db4755770454eb63685f8de785c0a172.js type=module></script>
<script src=/hu/js/wowchemy.min.4d23fe86388c1f4ad1e72b6d8a853e3c.js></script><div id=modal class="modal fade" role=dialog><div class=modal-dialog><div class=modal-content><div class=modal-header><h5 class=modal-title>Idézet</h5><button type=button class=close data-dismiss=modal aria-label=Close>
<span aria-hidden=true>&#215;</span></button></div><div class=modal-body><pre><code></code></pre></div><div class=modal-footer><a class="btn btn-outline-primary my-1 js-copy-cite" href=# target=_blank><i class="fas fa-copy"></i> Másolat</a>
<a class="btn btn-outline-primary my-1 js-download-cite" href=# target=_blank><i class="fas fa-download"></i> Letöltés</a><div id=modal-error></div></div></div></div></div><script src=/js/wowchemy-publication.68f8d7090562ca65fc6d3cb3f8f2d2cb.js type=module></script>
<script type=text/javascript>var sc_project=8274576,sc_invisible=1,sc_security="b688857d"</script><script type=text/javascript src=https://www.statcounter.com/counter/counter.js async></script><noscript><div class=statcounter><a title="ingyenes
webstatisztika" href=https://www.statcounter.hu/ target=_blank><img class=statcounter src=https://c.statcounter.com/8274576/0/b688857d/1/ alt="ingyenes webstatisztika" referrerpolicy=no-referrer-when-downgrade></a></div></noscript></body></html>